ClinicalTrials.Veeva

Menu
N

National Allergy and Asthma Research LLC | North Charleston, SC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dupilumab
Albuterol Sulfate
Fluticasone Propionate
OPN-375
Rocatinlimab
EVO756
Bradanicline
CDX-0159
Symbicort®
NOC-110

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 26 total trials

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis (Adoring)

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 2...

Active, not recruiting
Atopic Dermatitis
Drug: Vehicle Cream
Drug: Tapinarof cream, 1%

The primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic m...

Active, not recruiting
Asthma
Drug: TEV-56248
Drug: Albuterol sulfate

The main objective of the study is to assess efficacy and safety of dupilumab given up to 24 weeks in adults with CPUO.This is a master protocol whic...

Enrolling
Pruritus
Drug: Placebo
Drug: Dupilumab

This study will test an experimental study medicine called REGN20423 to see how effective it is in healthy participants (in Part A) and participants...

Enrolling
Atopic Dermatitis
Healthy Volunteer
Other: Placebo
Drug: REGN20423

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Active, not recruiting
Refractory or Unexplained Chronic Cough
Drug: NOC-110
Other: Placebo

Trial sponsors

Regeneron Pharmaceuticals logo
A
E
LEO Pharma logo
Sanofi logo
T
Amgen logo
AnaptysBio logo
A
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems